Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xadcera Biopharmaceutical (suzhou) Co., Ltd.

Clinical trials sponsored by Xadcera Biopharmaceutical (suzhou) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new drug DM001 take on advanced solid tumors? Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New drug DM002 enters first human tests for Hard-to-Treat cancers

Disease control Recruiting now

This early-phase study tests an experimental drug called DM002 in about 160 people with advanced solid tumors (ovarian, prostate, endometrial, colorectal, or other solid cancers). The study has two parts: first, finding a safe dose by giving small groups gradually higher doses; s…

Phase 1/2 • Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC